PURPOSE Atrial fibrillation (AF) is the most frequent arrhythmia that follows coronary artery bypass graft (CABG). Patients developing postoperative AF (POAF) have significantly higher mortality rates. The consistent prophylactic effectiveness of statins and vitamin C are well-accepted; however, no evaluation on combined therapy has been performed. We aimed at assessing the efficacy of combinat...

OBJECTIVE To summarise the potential consequences of atrial fibrillation (AF) after coronary artery bypass graft surgery (CABG) and the relationship of the arrhythmia with serum magnesium concentration ([Mg]) and to review the trials of magnesium supplementation as prophylaxis against post-CABG AF. DATA SOURCES Abstracts, articles and published reviews on AF after CABG and magnesium prophylax...

Coronary artery bypass graft surgery (CABG) is the gold standard treatment for relieving angina symptoms and reducing mortality among ischemic heart disease patients. As post-operative thrombosis of the grafts has been a frequent complication of CABG, antiplatelet therapy remains essential to maintain graft patency. Since a long time, aspirin has been used as a single anti-platelet agent post C...

BACKGROUND Current guidelines recommend early P2Y12 inhibitor administration in non-ST-elevation myocardial infarction, but it is unclear if precatheterization use is associated with longer delays to coronary artery bypass grafting (CABG) or higher risk of post-CABG bleeding and transfusion. This study examines the patterns and outcomes of precatheterization P2Y12 inhibitor use in non-ST-elevat...

Objective: Atrial ®brillation (AF) is common after coronary artery bypass graft (CABG) surgery. Atrial ischaemia due to diseased atrioventricular (AV) and sinoatrial (SA) arteries has been proposed as a cause of AF post-CABG. We examined if the presence of diseased nodal arteries was a signi®cant predictor of the development of AF post-CABG. Methods: 100 consecutive cases (AF post-CABG) were co...